13F Pro

SEC Form 4 reporting owner

Rodriguez Javier

Rodriguez Javier has filed 15 Form 4 transactions reported between December 14, 2025 and June 16, 2026, as Chief Executive Officer of DAVITA INC., a reporting owner of BioXcel Therapeutics, Inc. and Director of GILEAD SCIENCES, INC..

Name as filed: Rodriguez Javier

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$14.5M
3 lines
Companies
3
with Form 4 filings
Latest transaction
Jun 16, 2026
transaction date

Roles and reported holdings

  • DVADAVITA INC.
    Mar 15, 2026 – Jun 16, 2026

    Chief Executive Officer

    Held directly840,408 sh as of Jun 16, 2026 · Form 4

    24 months: $14.5M sold

  • BTAIBioXcel Therapeutics, Inc.
    Dec 14, 2025 – Jun 15, 2026

    Reporting owner

    Held directly26,803 sh as of May 20, 2026 · Form 4

    24 months: $7K sold

  • GILDGILEAD SCIENCES, INC.
    Apr 30, 2026

    Director

    No common-stock holding reported on a purchase, sale, gift or withholding line.

Transaction history

All 15 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Jun 16, 2026DVAChief Executive OfficerOpen-market saleCode S · direct39,407$8.2M@ $209.28Form 4
Jun 15, 2026DVAChief Executive OfficerOpen-market saleCode S · direct30,000$6.3M@ $209.50Form 4
Jun 15, 2026BTAIOption exerciseCode M · direct35—Form 4
May 20, 2026BTAIOpen-market saleCode S · direct6,560$7K@ $1.08Form 4
May 4, 2026BTAIOption exerciseCode M · direct17,500—Form 4
May 1, 2026BTAIOption exerciseCode M · direct9,000—Form 4
Apr 30, 2026GILDDirectorGrant or awardCode A · direct4,884—Form 4
Apr 30, 2026GILDDirectorGrant or awardCode A · direct1,146—Form 4
Mar 15, 2026BTAIOption exerciseCode M · direct35—Form 4
Mar 15, 2026DVAChief Executive OfficerGrant or awardCode A · direct56,506—Form 4
Mar 15, 2026DVAChief Executive OfficerGrant or awardCode A · direct20,900—Form 4
Mar 14, 2026BTAIOption exerciseCode M · direct33—Form 4
Jan 1, 2026BTAIGrant or awardCode A · direct70,000—Form 4
Dec 15, 2025BTAIOption exerciseCode M · direct35—Form 4
Dec 14, 2025BTAIOption exerciseCode M · direct33—Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.